Analyze awards, watch incumbents and competitors, track new transactions or changes, and use award history to shape recompete and capture strategy.
Award ID | Description | Recipient | Total Value | Awarding Agency | Funding Agency | Set Aside | NAICS | PSC | Award Date | Start Date | End Date | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IGF::OT::IGF PHASE 2 CLINICAL TRIAL | HUMACYTE GLOBAL, INC | $4,025,472 | DEPT OF THE ARMY | DEPT OF THE ARMY | — | 541711 | AN94 | Sep 25, 2017 | Sep 30, 2017 | Mar 29, 2020 | ||
| IGF::OT::IGF VASCULAR INTERVENTIONS/INNOVATIONS ANDTHERAPEUTIC ADVANCES (VITA): BIOENGINEEREDGRAFTS FOR PERIPHERAL VASCULAR DISEASE FOR BASEPERIOD: NOVEMBER 15, 2013 - NOVEMBER 14, 2014 | HUMACYTE GLOBAL, INC | $1,570,756 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541712 | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Nov 14, 2013 | Nov 14, 2013 | Nov 14, 2016 |